Retroperitoneal Lymph Node Dissection Perioperative Management and Updates on Surgical Techniques

被引：0
作者：
Zeng, Jiping [1 ]
Cary, Clint [1 ]
Masterson, Timothy A. [1 ]
机构：
[1] Indiana Univ, Dept Urol, Indianapolis, IN 46202 USA
来源：
UROLOGIC CLINICS OF NORTH AMERICA | 2024年 / 51卷 / 03期
关键词：
RPLND; Testicular cancer; ERAS; Tumor markers; MicroRNA; Robotic RPLND; Complications; POSITRON-EMISSION-TOMOGRAPHY; GERM-CELL TUMORS; CLINICAL STAGE-I; TESTICULAR CANCER; POSTCHEMOTHERAPY SEMINOMA; CHEMOTHERAPY; TESTIS; CARE; LYMPHADENECTOMY; COMPLICATIONS;
D O I：
10.1016/j.ucl.2024.03.009
中图分类号：
R5 [内科学]; R69 [泌尿科学（泌尿生殖系疾病）];
学科分类号：
1002 ; 100201 ;
摘要：
In this review, we summarized the current advances in perioperative management and the evolution of surgical techniques in RPLND. Decades of global experience have contributed to our understanding of RPLND, resulting in an acceptable morbidity rate and a well -established management algorithm for complications. We anticipate RPLND to continue evolving and expanding its role in the management of GCT.
引用
收藏
页码：407 / 419
页数：13
相关论文
共 70 条
  • [1] Postoperative Acute Respiratory Distress Syndrome in Patients With Previous Exposure to Bleomycin
    Aakre, Benjamin M.
    Efem, Richard I.
    Wilson, Gregory A.
    Kor, Daryl J.
    Eisenach, John H.
    [J]. MAYO CLINIC PROCEEDINGS, 2014, 89 (02) : 181 - 189
  • [2] Outcomes of post-chemotherapy robot-assisted retroperitoneal lymph node dissection in testicular cancer: multi-institutional study
    Abdul-Muhsin, Haidar
    Rocco, Nicholas
    Navaratnam, Anojan
    Woods, Michael
    L'Esperance, James
    Castle, Erik
    Stroup, Sean
    [J]. WORLD JOURNAL OF UROLOGY, 2021, 39 (10) : 3833 - 3838
  • [3] Alsyouf M, 2022, J UROLOGY, V207, pE773
  • [4] 2-18fluoro-deoxy-D-glucose positron emission tomography (FDG-PET) for postchemotherapy seminoma residual lesions: a retrospective validation of the SEMPET trial
    Bachner, M.
    Loriot, Y.
    Gross-Goupil, M.
    Zucali, P. A.
    Horwich, A.
    Germa-Lluch, J. -R.
    Kollmannsberger, C.
    Stoiber, F.
    Flechon, A.
    Oechsle, K.
    Gillessen, S.
    Oldenburg, J.
    Cohn-Cedermark, G.
    Daugaard, G.
    Morelli, F.
    Sella, A.
    Harland, S.
    Kerst, M.
    Gampe, J.
    Dittrich, C.
    Fizazi, K.
    De Santis, M.
    [J]. ANNALS OF ONCOLOGY, 2012, 23 (01) : 59 - 64
  • [5] Becherer A, 2011, METHODS MOL BIOL, V727, P225, DOI 10.1007/978-1-61779-062-1_13
  • [6] Is full bilateral retroperitoneal lymph node dissection always necessary for postchemotherapy residual tumor?
    Beck, Stephen D. W.
    Foster, Richard S.
    Bihrle, Richard
    Donohue, John P.
    Einhorn, Lawrence H.
    [J]. CANCER, 2007, 110 (06) : 1235 - 1240
  • [7] Post chemotherapy RPLND in patients with elevated markers: Current concepts and clinical outcome
    Beck, Stephen D. W.
    Foster, Richard S.
    Bihrle, Richard
    Einhorn, Lawrence H.
    Donohue, John P.
    [J]. UROLOGIC CLINICS OF NORTH AMERICA, 2007, 34 (02) : 219 - +
  • [8] Robotic retroperitoneal lymph node dissection for testicular cancer at a national referral centre
    Bergdahl, Anna Grenabo
    Mansson, Marianne
    Holmberg, Goran
    Fovaeus, Magnus
    [J]. BJUI COMPASS, 2022, 3 (05): : 363 - 370
  • [9] Improving postoperative quality of care in germ cell tumor patients: Does scheduled alvimopan, acetaminophen, and gabapentin improve short-term clinical outcomes after retroperitoneal lymph node dissection?
    Calaway, Adam C.
    Foster, Richard S.
    Tong, Yan
    Masterson, Timothy A.
    Bihrle, Richard
    Cary, Clint
    [J]. UROLOGIC ONCOLOGY-SEMINARS AND ORIGINAL INVESTIGATIONS, 2020, 38 (04) : 305 - 312
  • [10] Adverse Surgical Outcomes Associated with Robotic Retroperitoneal Lymph Node Dissection Among Patients with Testicular Cancer
    Calaway, Adam C.
    Einhorn, Lawrence H.
    Masterson, Timothy A.
    Foster, Richard S.
    Cary, Clint
    [J]. EUROPEAN UROLOGY, 2019, 76 (05) : 607 - 609
1234567